Navigation Links
Accuray Announces Rapid Clinical Adoption of TomoDirect™ Treatment Delivery Mode
Date:10/26/2011

SUNNYVALE, Calif., Oct. 26, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today significant momentum in global adoption of its TomoDirect treatment modality. More than 100 systems are now in use at leading cancer centers throughout the world, offering patients the option of treatment with image-guided, intensity-modulated radiation therapy (IG-IMRT) for routine radiation therapy indications.

First delivered to the market in 2010, TomoDirect is a standard feature on the TomoHD™ Treatment System. It is optimized for delivering radiation at fixed angles, making it highly efficient for whole breast radiotherapy and other cases where select beam angles are most appropriate. Global adoption continues, with over 75 percent of system orders in the past six months including TomoDirect.

The Institute for Image-Guided RadioTherapy (IIGRT) in Westchester, Rye, New York is one of the first centers in the world to offer TomoDirect treatments. IIGRT performs both whole breast and accelerated partial breast irradiation (APBI) with TomoDirect.

"IIGRT has been using the TomoTherapy System since 2007 and we have significantly increased our treatment capacity with the addition of TomoDirect last year, because we can now offer TomoTherapy to an expanded patient population," said Dr. Daniel Fass, director of IIGRT. "TomoDirect offers a highly accurate and convenient method for delivering APBI. This allows us to offer many breast cancer patients a shorter course of high quality radiation therapy tr
'/>"/>

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Accuray Incorporated to Speak at 2011 Wedbush Life Sciences: Management Access Conference
2. SEC Declares Accuray Form S-4 Registration Statement Effective in Proposed Acquisition of TomoTherapy
3. Accuray Incorporated to Report Financial Results for Second Quarter of Fiscal 2011
4. Accuray Incorporated to Speak at Seventh Annual Lazard Capital Markets Healthcare Conference
5. Accuray Incorporated to Speak at Wells Fargo Securities Healthcare Conference
6. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO
7. Accuray Incorporated to Present at Robert Baird 2009 Healthcare Conference
8. Accuray to Showcase CyberKnife Treatment Planning Capabilities at Preeminent Radiation Oncology Conference
9. 10 Percent of U.S. Installed Base Signs on to Use Accuray Treatment Planning Service
10. Accuray Incorporated to Report Second Quarter Fiscal Year 2009 Financial Results
11. Accuray Incorporateds CEO to Speak at 27th Annual JP Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013  Personal Genome ... use its proprietary methodologies and expertise in genomic ... kinase targets in collaboration with Blueprint Medicines.  PGDx ... at identifying genomic alterations in tumors, and Blueprint ... kinase inhibitors for a genetically defined patient population. ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Revolutionary Science, ... automatic colony counter, announced today that they have expanded ... products , the IncuCount, IntelliCount, InCount and ImpressCount. ... sophistication are especially useful in food microbiology and pharmaceutical ... an updated look. A bright white enclosure with ...
(Date:5/21/2013)... 21, 2013 Inflamax scientists worked ... ITN to design the study, which will provide ... clinical models used in the study of allergy ... Allergen Challenge (NAC) models. Although both the models ... to date no direct comparison between the allergic ...
(Date:5/21/2013)... MA (PRWEB) May 21, 2013 Possible mold ... And so, according to a report from eagletribune.com posted May ... mold. In case the result is positive, My Cleaning Products ... using harmful chemical ingredients. , It was said in the ... re-infestation in the campus sparked after a first-grade classroom ...
Breaking Biology Technology:Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 2Personal Genome Diagnostics And Blueprint Medicines Form Collaboration to Identify Novel Kinase Targets 3Revolutionary Science Announces New Automatic and Manual Colony Counting Products 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 2Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive 3
... that has sped to the finals in the Governor's ... annual flu vaccine hoopla, among other things. , ,Founders Curtis ... drugs based on antiviral peptides discovered in Brandt's lab. One ... targets some sexually transmitted viruses such as HIV and herpes. ...
... human thumbnail, but they can hold over a half of ... technology offers a view of so many tiny bits of ... 30,000 genes of the human genome, which are one of ... tiny dots of sample material on them, give scientists a ...
... Bextra from the marketplace clearly jolted both Pfizer and the market. ... ago and its stock has declined from $38 per share a ... recently moved up to the $27 level. , ,This activity still ... months. , ,Though Pfizer still leads the industry with a market ...
Cached Biology Technology:UW-Madison spinoff Pedrus finds more to business planning than good science 2UW-Madison spinoff Pedrus finds more to business planning than good science 3Madison biochip research offers geneticists a big view through a small window 2Madison biochip research offers geneticists a big view through a small window 3Why are new drugs failing? 2Why are new drugs failing? 3Why are new drugs failing? 4Why are new drugs failing? 5Why are new drugs failing? 6
(Date:5/21/2013)... have found that a class of pharmaceuticals can both ... The drugs, known as "TSPO ligands," are currently used ... the effects of TSPO ligand in young adult mice ... aged mice when pathology was quite severe," said lead ... Gerontology. "TSPO ligand reduced measures of pathology and improved ...
(Date:5/21/2013)... stores, phosphatidylserine is a natural food supplement produced ... cognition and slow memory loss, it,s a popular ... a team headed by Prof. Gil Ast and ... of Human Molecular Genetics have discovered ... genes involved in degenerative brain disorders, including Parkinson,s ...
(Date:5/21/2013)... decades, scientists have developed many devices that can reopen ... generally effective, each of these treatments has drawbacks, including ... from MIT analyzes the potential usefulness of a new ... drug-releasing stents, but may pose fewer risks. With this ... for only a brief period, during which it releases ...
Breaking Biology News(10 mins):Drugs found to both prevent and treat Alzheimer's disease in mice 2Common food supplement fights degenerative brain disorders 2Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3
... University of Southern California have made a significant breakthrough ... a synthetic brain. They have built a carbon nanotube ... of a neuron, the building block of the brain. ... Parker and Professor Chongwu Zhou in the USC Viterbi ...
... treating disease. But can they work better, and safer? ... challenge of administering therapeutics in a way that boosts their ... their potential damage to healthy tissue. The ... drugs and release them directly into cells holds great potential ...
... Carolina State University have discovered how fat, oil and ... it turns into soap! The hardened deposits, which can ... found that FOG deposits in sewage collection systems are ... from FOG into, basically, a huge lump of soap," ...
Cached Biology News:Researchers create functioning synapse using carbon nanotubes 2Scientists engineer nanoscale vaults to encapsulate 'nanodisks' for drug delivery 2Scientists engineer nanoscale vaults to encapsulate 'nanodisks' for drug delivery 3Researchers find fat turns into soap in sewers, contributes to overflows 2